LABORATOIRES FILL-MED MANUFACTURING
0508.506.959 · rovalta.com · 27/09/2026
LABORATOIRES FILL-MED MANUFACTURING
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOLABORATOIRES FILL-MED MANUFACTURING is a Public limited company incorporated in 2012. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Anderlecht. It employs on average 36,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0508.506.959
- Incorporation
- 18/12/2012
- Legal form
- Public limited company
- Registered office
- Boulevard Paepsem 18
1070 Anderlecht · BruxellesSee on map - Contributed capital
- 61 500,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 36,0 ETP
Joint committees (1)
- 207
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 17,1 M € | -27.0% | 23,5 M € | -7.4% | 25,3 M € | -31.8% | 37,1 M € | +13.4% | 32,8 M € |
| EBITDA | 1,2 M € | -77.4% | 5,1 M € | -16.6% | 6,1 M € | -64.3% | 17,1 M € | -16.2% | 20,4 M € |
| Operating result | 1,7 M € | -43.8% | 3 M € | -45.3% | 5,5 M € | -66.4% | 16,5 M € | -17.3% | 20 M € |
| Net result | 1,3 M € | -45.5% | 2,3 M € | -46.4% | 4,3 M € | -65.2% | 12,3 M € | -17.4% | 14,9 M € |
| Balance sheet | |||||||||
| Equity | 5,8 M € | -11.7% | 6,5 M € | -9.9% | 7,3 M € | -9.2% | 8 M € | +39.5% | 5,7 M € |
| Total assets | 24,3 M € | -15.8% | 28,9 M € | -10.6% | 32,3 M € | -18.9% | 39,9 M € | +29.5% | 30,8 M € |
| Cash | 315,8 k € | -72.7% | 1,2 M € | +437% | 215,9 k € | +29.1% | 167,2 k € | -71.5% | 587,3 k € |
| Debts | 18,5 M € | -11.5% | 20,9 M € | -16.2% | 24,9 M € | -21.2% | 31,6 M € | +26.8% | 24,9 M € |
| Other | |||||||||
| Workforce | 36,0 ETP | +2.3% | 35,2 ETP | -3.6% | 36,5 ETP | +19.7% | 30,5 ETP | +26.0% | 24,2 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 18 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/04/2026 | 23/04/2025 | 23/04/2024 | 11/04/2023 | 26/04/2022 | 30/04/2021 |
| General meeting | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 31/03/2026 | 15/04/2026 | French | |
| Full model | 31/12/2024 | 31/03/2025 | 23/04/2025 | French | |
| Full model | 31/12/2023 | 31/03/2024 | 23/04/2024 | French | |
| Full model | 31/12/2022 | 31/03/2023 | 11/04/2023 | French | |
| Full model | 31/12/2021 | 31/03/2022 | 26/04/2022 | French | |
| Full model | 31/12/2020 | 31/03/2021 | 30/04/2021 | French | |
| Full model | 31/12/2019 | 31/03/2020 | 28/05/2020 | French | |
| Full model | 31/12/2018 | 30/04/2019 | 24/05/2019 | French | |
| Full model | 31/12/2017 | 30/05/2018 | 05/06/2018 | French | |
| Full model | 31/12/2016 | 30/05/2017 | 26/06/2017 | French | |
| Full model | 31/12/2015 | 30/04/2016 | 20/06/2016 | French | |
| Full model | 31/12/2014 | 29/09/2015 | 05/10/2015 | French | |
| Full model | 31/12/2013 | 30/05/2014 | 27/08/2014 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 18 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates22/05/2024DEMISSIONS, NOMINATIONS
- Mandates06/03/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DIVERS - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
- Mandates02/02/2022DEMISSIONS, NOMINATIONS
- Mandates10/05/2021DEMISSIONS, NOMINATIONS
- Mandates07/03/2019DEMISSIONS, NOMINATIONS
- Mandates01/08/2018DEMISSIONS, NOMINATIONS
- Mandates05/02/2018DENOMINATION
- Mandates13/07/2017DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,3 M €↓
- 2024Annual accounts 20242,3 M €↓
- 2023Annual accounts 20234,3 M €↓
- 2022Annual accounts 202212,3 M €↓
- 2021Annual accounts 202114,9 M €↑
- 2020Annual accounts 20205,6 M €↑
- 2019Annual accounts 20195,1 M €↑
- 2018Annual accounts 20184,1 M €↑
- 2017Annual accounts 20172,9 M €↑
- 2016Annual accounts 20161,8 M €↑
- 2015Annual accounts 2015-2,2 M €↓
- 2014Annual accounts 2014-1,2 M €↓
- 2013Annual accounts 2013-473,6 k €
- 18/12/2012IncorporationPublic limited company